Literature DB >> 447613

Functioning of mitochondria-bound hexokinase in rat brain in accordance with generation of ATP inside the organelle.

M Inui, S Ishibashi.   

Abstract

The function of mitochondria-bound hexokinase, the enzymatic form peculiar to the brain, in utilization of ATP generated inside the organelles, was examined by incubating rat brain mitochondrial fraction with [14C]glucose under various conditions. Addition of succinate and ADP to the incubation medium increased glucose 6-phosphate formation by the mitochondrial hexokinase and caused a smaller increase in ATP concentration in the mitochondria. The glucose phosphorylation was markedly inhibited by the addition of dinitrophenol, potassium cyanide, and oligomycin, and the ATP concentration was decreased. On the other hand, addition of atractyloside suppressed the glucose phosphorylation without affecting the mitochondrial hexokinase activity, whereas addition of antiserum against the mitochondrial hexokinase inhibited both glucose 6-phosphate formation and hexokinase activity. A part of both the glucose phosphorylation and hexokinase activities, however, remained even in the presence of the maximum dose of the anti-hexokinase serum and atractyloside. These results indicate the active utilization of intrinsically generated ATP by the mitochondria-bound hexokinase, a part of which may be located away from the surface of the mitochondrial membrane.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 447613

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  11 in total

1.  NADH is specifically channeled through the mitochondrial porin channel in Saccharomyces cerevisiae.

Authors:  N Avéret; H Aguilaniu; O Bunoust; L Gustafsson; M Rigoulet
Journal:  J Bioenerg Biomembr       Date:  2002-12       Impact factor: 2.945

Review 2.  The cation-selective substate of the mitochondrial outer membrane pore: single-channel conductance and influence on intermembrane and peripheral kinases.

Authors:  R Benz; D Brdiczka
Journal:  J Bioenerg Biomembr       Date:  1992-02       Impact factor: 2.945

3.  Binding of rat brain hexokinase to recombinant yeast mitochondria: effect of environmental factors and the source of porin.

Authors:  C Aflalo; H Azoulay
Journal:  J Bioenerg Biomembr       Date:  1998-06       Impact factor: 2.945

4.  Purification and characterization of the pore forming protein of yeast mitochondrial outer membrane.

Authors:  O Ludwig; J Krause; R Hay; R Benz
Journal:  Eur Biophys J       Date:  1988       Impact factor: 1.733

Review 5.  Microcompartmentation of energy metabolism at the outer mitochondrial membrane: role in diabetes mellitus and other diseases.

Authors:  E R McCabe
Journal:  J Bioenerg Biomembr       Date:  1994-06       Impact factor: 2.945

6.  Effects of thiopental on regulatory mechanisms of brain energy metabolism.

Authors:  J Krieglstein; G Sperling; G Twietmeyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-12       Impact factor: 3.000

7.  Relationship between brain mitochondrial hexokinase and neuronal function: comparable effects of 2-deoxy-D-glucose and thiopental.

Authors:  J Krieglstein; G Sperling; R Stock
Journal:  Neurochem Res       Date:  1982-06       Impact factor: 3.996

Review 8.  Hexokinase-binding properties of the mitochondrial VDAC protein: inhibition by DCCD and location of putative DCCD-binding sites.

Authors:  R A Nakashima
Journal:  J Bioenerg Biomembr       Date:  1989-08       Impact factor: 2.945

Review 9.  Organization and regulation of the cytosolic NADH metabolism in the yeast Saccharomyces cerevisiae.

Authors:  Michel Rigoulet; Hugo Aguilaniu; Nicole Avéret; Odile Bunoust; Nadine Camougrand; Xavier Grandier-Vazeille; Christer Larsson; Inga-Lill Pahlman; Stephen Manon; Lena Gustafsson
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

10.  Comparison of rat brain and heart mitochondrial hexokinase solubilized by methohexital.

Authors:  L Karcher; A Rachman; J Krieglstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.